Crossmark

Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomization

Crossref DOI link: https://doi.org/10.1186/s12888-025-06914-0

Published Online: 2025-05-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Lingfeng https://orcid.org/0000-0002-2216-5207
Chen, Xiang

Xu, Yantao https://orcid.org/0000-0001-5410-0312
Liu, Jiachen

Liu, Zhongchun
Funding

Funding for this research was provided by:

National Key Research and Development Project of China (2024YFC3308400)

National Natural Science Foundation of China (U21A20364)
License Information

Text and Data Mining valid from 2025-05-14

Version of Record valid from 2025-05-14
More Information

Article History

Received: 4 November 2024

Accepted: 27 April 2025

First Online: 14 May 2025

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below